SPAAR and colorectal carcinoma: In the AOM model of CRC, mice exposed to TX20005 showed a significantly higher tumor burden compared to mice treated with saline, whereas mice gavaged with the SPAR mutant showed no difference in tumor burden compared to the saline control.